Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
ID04772131

Prospective, Post-market Study of the Desara4 One Single Incision Sling vs. Desara4 Blue Sling Implanted Via the Transobturator Route for the Treatment of Women With Stress Urinary Incontinence

Led by Caldera Medical, Inc. · Updated on 2025-09-19

300

Participants Needed

15

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the safety and effectiveness of the Desara4 One Single Incision Sling (SIS) compared to the Desara4 Blue sling system implanted through the transobturator-route (TOR) to treat women with stress urinary incontinence (SUI). This study involves adult females experiencing SUI due to urethral hypermobility and/or intrinsic sphincter deficiency (ISD). The study is prospective, non-randomized, and conducted at multiple centers over 36 months. The study compares two devices: the Desara4 One Single Incision Sling and the Desara4 Blue Transobturator Sling. Each device will be implanted in separate groups of 150 participants. Follow-up visits are scheduled at 2 and 6 weeks, then at 6, 12, 18, 24, and 36 months after implantation. Participants may also undergo concomitant laparoscopic, robotic, or vaginal prolapse repair surgeries if needed. Participants will attend regular visits for evaluations including cough stress tests, sexual function assessments, pain assessments, and urinary symptom improvements. Researchers will monitor serious adverse events related to the devices and procedures, as well as measure success rates of negative cough stress tests at 36 months. The total study participation spans three years with multiple assessments to track outcomes and safety.

CONDITIONS

Brief Title

Desara ® One Single Incision Sling 522 Study

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female aged 18 years or older
  • Willing and able to return for all study procedures and evaluations
  • Provided signed informed consent
  • Stress urinary incontinence confirmed by cough stress test with bladder pre-fill or ultrasound
  • Stress incontinence greater than urge incontinence per MESA questionnaire
  • No childbearing capacity or negative pregnancy test and decided to cease childbearing, confirmed by hysterectomy, tubal ligation, inability to become pregnant, or negative pregnancy test
  • Offered and failed or refused non-invasive SUI treatments and elected surgical intervention
  • Eligible for laparoscopic/robotic or vaginal prolapse repair procedures if needed
Not Eligible

You will not qualify if you...

  • Baseline pelvic pain of 2 or greater on a 10-point scale
  • Known neurological disease or neurogenic bladder symptoms
  • Known pre-existing pain syndrome or evaluated by pain management physician
  • History of chronic opioid or narcotic use
  • On anticoagulation therapy that cannot be stopped or adjusted before surgery
  • On chronic systemic steroid treatment longer than 3 months (except inhalational use)
  • Uncontrolled diabetes with A1c 7% or higher or fasting glucose over 130 mg/dl
  • Active skin infection or lesion in the perineum, urethra, or vagina
  • Active urinary tract infection requiring treatment
  • Recurrent UTIs (3 or more in the past 6 months)
  • Urethral obstruction or anatomic defects of the urethra
  • Prior surgical treatment for stress urinary incontinence or prior pelvic floor mesh use or complications
  • Conditions compromising implant placement or pelvic blood supply
  • Bladder stones or tumors
  • Abnormal bladder capacity less than 300 mL
  • Post void residual volume 150 mL or greater on two measurements
  • Previous pelvic radiation or brachytherapy
  • Enrolled in another clinical trial affecting continence or outcomes
  • Known allergy or sensitivity to polypropylene

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Day of surgery

Participants undergo implantation of either the Desara® One Single Incision Sling or the Desara® Blue Transobturator Sling to treat stress urinary incontinence.

1 visit (in-person)

Post-operative Follow-up

Duration - 36 months

Participants are monitored with follow-up visits to assess treatment outcomes and safety after sling implantation.

Follow-up visits at 2 and 6 weeks, 6, 12, 18, 24, and 36 months

Trial Site Locations

Total: 15 locations

1

Valley Urogynecology Associates, Inc.

Phoenix, Arizona, United States, 85016

Actively Recruiting

2

University of Arizona College of Medicine

Tucson, Arizona, United States, 85724

Not Yet Recruiting

3

Urological Research Center Corp

Hialeah, Florida, United States, 33016

Actively Recruiting

4

Women's Health Care Associates P.A. dba Rosemark Women Care Specialists

Idaho Falls, Idaho, United States, 83404

Actively Recruiting

5

CMB Research, LLC

Newburgh, Indiana, United States, 47630

Actively Recruiting

6

University of Louisville

Louisville, Kentucky, United States, 40202

Actively Recruiting

7

Mt. Auburn Hospital Division of Urogynecology

Cambridge, Massachusetts, United States, 02138

Actively Recruiting

8

Specialty Clinical Research of St. Louis, LLC

St Louis, Missouri, United States, 631471

Actively Recruiting

9

Women's Cancer Center of Nevada

Las Vegas, Nevada, United States, 89169

Actively Recruiting

10

University of New Mexico

Albuquerque, New Mexico, United States, 87131

Actively Recruiting

11

Novant Health Urogynecology

Charlotte, North Carolina, United States, 28210

Actively Recruiting

12

The Lindner Research Center at The Christ Hospital

Cincinnati, Ohio, United States, 45219

Actively Recruiting

13

Center for Total Women's Health

Lansdale, Pennsylvania, United States, 19446

Actively Recruiting

14

Center for Pelvic Health

Franklin, Tennessee, United States, 37067

Actively Recruiting

15

University of Washington Medical Center

Seattle, Washington, United States, 98195

Actively Recruiting

Loading map...

Research Team

V

Vicki Gail

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Assessing the Utility of Prophylactic Antibiotics at Time of...

Stress Urinary Incontinence

Actively Recruiting

1 location

Assessment of Pelvic Floor Muscle Training Using Modern Cons...

Stress Urinary Incontinence

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here